Background: Hospital-acquired acute kidney injury is associated with increased mortality and has major public health implications. The incidence of in-hospital AKI in Eastern Saudi Arabia is not known.
Aims: To determine the incidence of in-hospital acute kidney injury in Eastern Saudi Arabia.
Methods: A single centre, retrospective cohort study at a major community hospital between July 2015 and July 2017.
Results: A total of 26 383 patients were hospitalized and 293 (1.11%) were diagnosed with acute kidney injury. Drug-induced AKI was diagnosed in 38 (13%) patients, while 255 (87%) patients had acute kidney injury not attributed to drugs. Full recovery of renal function was observed in 39% and 44% in the drug induced and non-drug induced acute kidney injury groups, respectively.
Conclusions: acute kidney injury is a serious complication in hospitalized patients. Full recovery of renal function was observed in a minority of patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.26719/emhj.19.100 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery-Reply.
JAMA
January 2025
Institut de Investigació Biomédica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children: Authors' Reply.
Indian J Pediatr
January 2025
Department of Microbiology, Amala Institute of Medical Sciences, Thrissur, Kerala, 680555, India.
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort.
J Nephrol
January 2025
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.
Background: In an Italian cohort of lupus podocytopathy patients, we aimed to characterize the presenting features, therapy, and outcomes, and explore differences between relapsing and non-relapsing patients.
Methods: We identified 29 patients with lupus podocytopathy from 1994 to 2023 in 11 Italian Nephrology/Rheumatology Units, and divided them into two groups: relapsing and non-relapsing. Given the limited sample size, a p-value ≤ 0.
Sotalol poisoning and its unique treatment considerations compared with traditional therapies for beta-adrenoceptor blocking drug poisoning.
Clin Toxicol (Phila)
January 2025
Minnesota Regional Poison Center, Minneapolis, MN, USA.
Introduction: Sotalol is a beta-adrenoceptor blocking drug with unique physical and pharmacologic properties. Unlike most beta-adrenoceptor blocking drugs, sotalol is amenable to extracorporeal removal and causes QT interval prolongation and ventricular dysrhythmias. These properties have implications for treating sotalol poisoning.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!